{"id":"W4399385857","doi":"10.1080/14728214.2024.2363213","title":"Emerging drugs for the treatment of benign prostatic hyperplasia: a 2023 update","year":2024,"lang":"en","type":"review","venue":"Expert Opinion on Emerging Drugs","topic":"Urinary Bladder and Prostate Research","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Toronto; Université de Montréal","funders":"","keywords":"Medicine; Lower urinary tract symptoms; Hyperplasia; cGMP-specific phosphodiesterase type 5; Benign prostatic hyperplasia (BPH); Intensive care medicine; Primary care; Primary treatment; Modalities; 5 Alpha-Reductase Inhibitor; Urology; Prostate; Internal medicine; Gynecology; Erectile dysfunction; Finasteride; Cancer; Family medicine","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001238459,0.000904754,0.001846603,0.004069724,0.00031905,0.001368541,0.0009786903,0.001642472,0.009103389],"category_scores_gemma":[0.002252071,0.0003116142,0.00144938,0.003808101,0.0003943543,0.001643759,0.0007487272,0.001744039,0.002333516],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001045907,"about_ca_system_score_gemma":0.00285639,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001891193,"about_ca_topic_score_gemma":0.005104042,"domain_scores_codex":[0.9994165,0.0001244065,0.0001287908,0.00006054106,0.0002235219,0.00004634969],"domain_scores_gemma":[0.9984056,0.0008345153,0.0002831607,0.00002672533,0.0003812971,0.0000687114],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.000129165,0.00005616998,0.0001406184,0.1102988,0.0002173589,0.000187704,0.00008328465,0.0001638288,0.0007884424,0.001761949,0.0445752,0.8415975],"study_design_scores_gemma":[0.00005409576,0.000156811,0.001140763,0.07781265,0.001026972,0.001166983,0.00009981952,0.00009758954,0.0002190653,0.001107291,0.9170952,0.00002278841],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.00007008605,0.9983037,0.00004556001,0.0004742368,0.0003063935,0.00001138543,0.00003997007,0.000006985594,0.0007416515],"genre_scores_gemma":[0.0003444588,0.9985616,0.0001383655,0.0004264925,0.0001697235,0.00001013052,0.00004789715,0.000001515661,0.0002998447],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.009103389,"threshold_uncertainty_score":0.03045386,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.07313921420710602,"score_gpt":0.4351080879869832,"score_spread":0.3619688737798772,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}